Tau Screening Study in Patients With Early Symptomatic AD

PHASE2CompletedINTERVENTIONAL
Enrollment

155

Participants

Timeline

Start Date

November 21, 2017

Primary Completion Date

August 31, 2018

Study Completion Date

August 31, 2018

Conditions
Alzheimer Disease
Interventions
DRUG

Flortaucipir F18

370 megabecquerel (MBq) IV single-dose

PROCEDURE

Brain PET Scan

positron emission tomography (PET) scan of the brain

Trial Locations (10)

19090

Abington Neurological Associates, Willow Grove

27103

PMG Research, Winston-Salem

32806

Bioclinica (Compass Research), Orlando

33445

Brain Matters Research, Delray Beach

33609

Axiom Clinical Research, Tampa

92103

Pacific Research Network, San Diego

92705

Syrentis Clinical Research, Santa Ana

02459

Boston Center for Memory, Newton

05201

The Memory Clinic, Bennington

M3B 2S7

Toronto Memory Program, Toronto

Sponsors
All Listed Sponsors
lead

Avid Radiopharmaceuticals

INDUSTRY